Ahmed Babiker, MBBS

Assistant Professor
Emory University
Atlanta, GA, United States

Dr. Ahmed Babiker is an Assistant Professor in the Department of Medicine, Division of Infectious Disease at Rush University. Dr. Babiker's primary research interest is the clinical and molecular epidemiology of multi-drug resistant healthcare-associated infections, the role of microbiome in colonization resistance and the antimicrobial resistance survillance in low- and middle income settings.

Disclosure(s): Beckman Coulter Inc.: Advisor/Consultant

Presentation(s):

• 311 - Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:42 AM – 10:54 AM US PT

• 312 - Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:54 AM – 11:06 AM US PT

• 431 - Engraftment of donor derived anaerobic taxa and durable long-term multidrug resistant organism decolonization following fecal microbiota transplantation

  Friday, October 18, 2024
  3:27 PM – 3:39 PM US PT